Virgina Wright
Family Health · Amarillo, TXNPI 1881070829
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 950 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Among family health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 950 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$2K
- UCB, Inc.$2K
- AstraZeneca$1K
- Johnson & Johnson$1K
- Pfizer$865
- plus $7K from 26 others
What the payments were for
- Food & beverage$16,31699%
- Education$2071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 168 | $2,469 |
| AbbVie | 118 | $2,134 |
| UCB, Inc. | 95 | $1,945 |
| AstraZeneca(2 entities) | 65 | $1,138 |
| Johnson & Johnson | 56 | $1,015 |
| Pfizer | 51 | $865 |
| GSK | 56 | $825 |
| Novartis | 42 | $820 |
| Radius Health, Inc. | 51 | $775 |
| ANI Pharmaceuticals, Inc. | 33 | $668 |
| Aurinia Pharma U.S., Inc. | 30 | $519 |
| Lilly USA, LLC | 28 | $488 |
| E.r. Squibb & Sons, L.L.C. | 32 | $432 |
| Genentech USA, Inc. | 30 | $424 |
| Mallinckrodt Hospital Products Inc. | 18 | $409 |
| Actelion Pharmaceuticals US, Inc. | 13 | $378 |
| Boehringer Ingelheim | 19 | $360 |
| Organon | 12 | $222 |
| Sobi, Inc | 5 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| Sanofi | 5 | $77 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Tersera Therapeutics LLC | 3 | $60 |
| Janssen Scientific Affairs, LLC | 2 | $51 |
| Scilex Pharmaceuticals Inc. | 2 | $34 |
| Mylan Institutional Inc. | 2 | $34 |
| Biocryst US Sales Co., LLC | 1 | $27 |
| Sandoz | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Eisai Inc. | 1 | $12 |
How this compares
$16,523 in reported general payments places this provider in the 95th percentile of 23 family health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 37 | $316,808 |
| Enbrel SureclickEtanercept | 30 | $269,856 |
| RinvoqUpadacitinib | 23 | $183,658 |
| OtezlaApremilast | 29 | $154,228 |
| Orencia ClickjectAbatacept | 15 | $92,006 |
| Actemra ActpenTocilizumab | 14 | $67,542 |
| Hydroxychloroquine Sulfate | 693 | $20,363 |
| MethotrexateMethotrexate Sodium | 448 | $9,872 |
| Leflunomide | 227 | $9,489 |
| Celecoxib | 203 | $6,278 |
| Gabapentin | 360 | $5,664 |
| Duloxetine Hcl | 223 | $4,685 |
| Colchicine | 98 | $4,436 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 162 | $3,872 |
| Mycophenolate Mofetil | 41 | $3,753 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $2,134 | $183,65823 claims |
| AmgenOtezla | $2,469 | $154,22829 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $34 | $4,43698 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 23 family health providers in Texas.
Other family health in Amarillo
- Laura MizellMontgomery$9K
- Carrie PhillipsForney$2K
- Kristine LunaCorpus Christi$2K
- Maricruz BloomquistWeslaco$2K
- Claudia GuillenWeatherford$2K
- Michelle UlrichAustin$1K
- Kimberly AustinWaco$1K
- Kimberly YoungPasadena$1K
- Tiffany GomezSan Antonio$889
- Terri SpeckFort Worth$424
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.